HPV VACCINES
 
HPV vaccines are currently being considered as a preventative measure against cervical cancer. HPV vaccines do not contain live virus particles. They only contain the virus's capsid protein structure. Therefore, when administered, they stimulate human immune cells as if the virus had entered the body, creating immunity. They are available in two-valent, four-valent, and nine-valent formulations. All of these vaccines protect against HPV types 16 and 18. The quadrivalent and nanovalent strains also protect against HPV types 6 and 11, which cause genital warts. The nanovalent strain also protects against HPV types 31, 33, 45, 52, and 58. The vaccine is usually administered in three doses, or in two doses for young adults.



















Vaccination can provide over 90% protection against precancerous lesions and warts in the genital system. Its effectiveness is particularly high when administered before the onset of sexual activity. However, initiation of sexual activity does not constitute a contraindication to vaccination. In other countries, it is included in the routine vaccination schedule for girls over the age of 9. Based on current information, it is known that booster doses are not necessary. Vaccination is not recommended during pregnancy, but it is believed that vaccination will not harm the baby.